Abstract
ObjectivesAssess the efficacy and safety of tocilizumab in patients with systemic sclerosis (SSc) in a phase II study.MethodsPatients with SSc were treated for 48 weeks in an open-label extension phase...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have